iX Biopharma Ltd. announced earnings results for the full year ended June 30, 2021. For the full year, the company announced sales was SGD 1.745 million compared to SGD 985,000 a year ago. Net loss was SGD 8.234 million compared to SGD 10.499 million a year ago. Basic loss per share from continuing operations was SGD 0.0078 compared to SGD 0.0073 a year ago.